Opus Biotech Communications
  • OUR FOCUS
  • CLIENTS
  • WHAT WE DO
  • WHO WE ARE
    • Strategic Alliance with Vanguard Group
  • NEWS & BLOG
    • OPUS Clients in the News
    • OPUS Biotech Communications Blog
    • Press Release Archives
  • CONTACT US
logo

OPUS Clients in the News

OPUS Press Release Archives

OPUS Biotech Communications Clients in the News

  • BioWorld: Kineta Crafting Seaworthy RIG in Cancer after Merck Sets Sail with German Buy.
  • Ovarian Cancer News: First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery
  • Practical Dermatology: Update from DFB Soria on Enrollment in Phase 2 Clinical Trial of Nanoparticle Paclitaxel Ointment for AK
  • Cancer Treatment: DFB Pharmaceuticals forms new company that could revolutionize cancer treatment
  • BioWorld: ‘Bare’-ish on naked effort, Nanology unveils particle approach across cancers.
  • Inside Perspectives: Gene Editing Takes Center Stage
  • WXPress: Will Immunotherapy Knock Out Cancer?
  • Inside Perspectives: Will Immunotherapy Knock Out Cancer?
  • Inside Perspectives on Cancer Immunotherapy: An Interview with TCR2 Therapeutics CEO Garry Menzel
  • Gut Instinct: Leveraging the Microbiome and Human Immune System to Dramatically Transform Medicine
  • Inside Perspectives on Cancer Immunotherapy: An Interview with Kineta’s Shawn Iadonato
  • Improving the Odds in Cancer With First-Time Immunotherapies
  • Inside Perspectives on Immunotherapy: An Interview with Advaxis CEO Daniel O’Connor

Our Focus
Clients
What We Do
Who We Are
News
Contact

© 2019OPUS Biotech Communications
Back to Top